https://www.selleckchem.com/pr....oducts/rgd-peptide-g
glucose dysregulation. These results indicate that 10-day use of CGM as a part of multimodal data collection, with synthesis and feedback to participants provided by a mobile health app, can significantly reduce hyperglycemia in non-insulin-treated individuals, including those with early stages of glucose dysregulation.Supplementary file1 [Video Language Matters in Diabetes] (MP4 151265 kb). This study aimed to examine retrospectively the clinical backgrounds of Japanese patients with type 2 diabetes (T2D) who successfully w
Gefällt mir
Kommentar
Teilen
